Results 331 to 340 of about 121,688 (385)
Oxidative Stress in Neurodegenerative Disorders: A Key Driver in Impairing Skeletal Muscle Health. [PDF]
Castelli S, Carinci E, Baldelli S.
europepmc +1 more source
Isolated Right Atrial Enhancement with Atrial Standstill: An Uncommon Presentation of Emery-Dreifuss Muscular Dystrophy. [PDF]
Biradar B+3 more
europepmc +1 more source
Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study. [PDF]
Li J+6 more
europepmc +1 more source
The Functions and Regulatory Mechanisms of Histone Modifications in Skeletal Muscle Development and Disease. [PDF]
Huang Z, Hu L, Liu Z, Wang S.
europepmc +1 more source
Reply to “Neurophysiological Testing to Diagnose Stiff‐Person Spectrum Disorder”
Movement Disorders Clinical Practice, EarlyView.
João Moura+5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neurologic Clinics, 2015
Progressive muscular atrophy (PMA) is a rare, sporadic, adult-onset motor neuron disease, clinically characterized by isolated lower motor neuron features; however, clinically evident upper motor neuron signs may emerge in some patients. Subclinical upper motor neuron involvement is identified pathologically, radiologically, and neurophysiologically in
Teerin Liewluck+2 more
openaire +4 more sources
Progressive muscular atrophy (PMA) is a rare, sporadic, adult-onset motor neuron disease, clinically characterized by isolated lower motor neuron features; however, clinically evident upper motor neuron signs may emerge in some patients. Subclinical upper motor neuron involvement is identified pathologically, radiologically, and neurophysiologically in
Teerin Liewluck+2 more
openaire +4 more sources
Nano letters (Print), 2023
Sarcopenia is known as age-related muscle atrophy, which influences over a quarter of the elderly population worldwide. It is characterized by a progressive decline in muscle mass, strength, and performance. To date, clinical treatments in sarcopenia are
Xi Yu+19 more
semanticscholar +1 more source
Sarcopenia is known as age-related muscle atrophy, which influences over a quarter of the elderly population worldwide. It is characterized by a progressive decline in muscle mass, strength, and performance. To date, clinical treatments in sarcopenia are
Xi Yu+19 more
semanticscholar +1 more source
2017
Progressive muscular atrophy is a chronic, sporadic, slowly progressive degeneration of the anterior horn cells and cranial nerve nuclei. It differs from amyotrophic lateral sclerosis in that there are no pyramidal signs. However, it has links and overlaps with amyotrophic lateral sclerosis. The condition needs to be considered in the wide differential
Bhagyadhan A. Patel+2 more
openaire +2 more sources
Progressive muscular atrophy is a chronic, sporadic, slowly progressive degeneration of the anterior horn cells and cranial nerve nuclei. It differs from amyotrophic lateral sclerosis in that there are no pyramidal signs. However, it has links and overlaps with amyotrophic lateral sclerosis. The condition needs to be considered in the wide differential
Bhagyadhan A. Patel+2 more
openaire +2 more sources
Progressive Muscular Atrophy in an Infant
The American Journal of Nursing, 1963D ON IS A TWO-MONTH-OLD boy with the infantile form of progressive muscular atrophy who was admitted to the pediatric service of a U.S. Air Force Hospital in England. In infants the condition is known as Werdnig-Hoffmann disease. This is primarily a disease of the anterior horn cells of the spinal cord, resulting in degeneration of the peripheral motor
openaire +3 more sources